231 related articles for article (PubMed ID: 29843991)
1. Lassa virus glycoprotein: stopping a moving target.
Hastie KM; Saphire EO
Curr Opin Virol; 2018 Aug; 31():52-58. PubMed ID: 29843991
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
[TBL] [Abstract][Full Text] [Related]
3. Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.
Li S; Sun Z; Pryce R; Parsy ML; Fehling SK; Schlie K; Siebert CA; Garten W; Bowden TA; Strecker T; Huiskonen JT
PLoS Pathog; 2016 Feb; 12(2):e1005418. PubMed ID: 26849049
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for antibody-mediated neutralization of Lassa virus.
Hastie KM; Zandonatti MA; Kleinfelter LM; Heinrich ML; Rowland MM; Chandran K; Branco LM; Robinson JE; Garry RF; Saphire EO
Science; 2017 Jun; 356(6341):923-928. PubMed ID: 28572385
[TBL] [Abstract][Full Text] [Related]
5. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
[TBL] [Abstract][Full Text] [Related]
6. Assays to Assess Arenaviral Glycoprotein Function.
Shao J; Liu X; Liang Y; Ly H
Methods Mol Biol; 2018; 1604():169-178. PubMed ID: 28986832
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Lassa virus glycan shield provides a model for immunological resistance.
Watanabe Y; Raghwani J; Allen JD; Seabright GE; Li S; Moser F; Huiskonen JT; Strecker T; Bowden TA; Crispin M
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7320-7325. PubMed ID: 29941589
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism for LAMP1 Recognition by Lassa Virus.
Cohen-Dvashi H; Cohen N; Israeli H; Diskin R
J Virol; 2015 Aug; 89(15):7584-92. PubMed ID: 25972533
[TBL] [Abstract][Full Text] [Related]
9. Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.
Acciani M; Alston JT; Zhao G; Reynolds H; Ali AM; Xu B; Brindley MA
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679759
[TBL] [Abstract][Full Text] [Related]
10. Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies.
Enriquez AS; Buck TK; Li H; Norris MJ; Moon-Walker A; Zandonatti MA; Harkins SS; Robinson JE; Branco LM; Garry RF; Saphire EO; Hastie KM
Cell Rep; 2022 May; 39(8):110841. PubMed ID: 35613585
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV.
Hastie KM; Igonet S; Sullivan BM; Legrand P; Zandonatti MA; Robinson JE; Garry RF; Rey FA; Oldstone MB; Saphire EO
Nat Struct Mol Biol; 2016 Jun; 23(6):513-521. PubMed ID: 27111888
[TBL] [Abstract][Full Text] [Related]
12. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones.
Meulen Jt; Badusche M; Satoguina J; Strecker T; Lenz O; Loeliger C; Sakho M; Koulemou K; Koivogui L; Hoerauf A
Virology; 2004 Mar; 321(1):134-43. PubMed ID: 15033572
[TBL] [Abstract][Full Text] [Related]
13. Lassa virus glycoprotein complex review: insights into its unique fusion machinery.
Pennington HN; Lee J
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35088070
[TBL] [Abstract][Full Text] [Related]
14. Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies.
Perrett HR; Brouwer PJM; Hurtado J; Newby ML; Liu L; Müller-Kräuter H; Müller Aguirre S; Burger JA; Bouhuijs JH; Gibson G; Messmer T; Schieffelin JS; Antanasijevic A; Boons GJ; Strecker T; Crispin M; Sanders RW; Briney B; Ward AB
Cell Rep; 2023 May; 42(5):112524. PubMed ID: 37209096
[TBL] [Abstract][Full Text] [Related]
15. Biochemical reconstitution of hemorrhagic-fever arenavirus envelope glycoprotein-mediated membrane fusion.
Thomas CJ; Shankar S; Casquilho-Gray HE; York J; Sprang SR; Nunberg JH
PLoS One; 2012; 7(11):e51114. PubMed ID: 23226473
[TBL] [Abstract][Full Text] [Related]
16. The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain.
Burri DJ; Pasquato A; da Palma JR; Igonet S; Oldstone MB; Kunz S
Virology; 2013 Feb; 436(1):127-33. PubMed ID: 23218200
[TBL] [Abstract][Full Text] [Related]
17. Myristoylation of the Arenavirus Envelope Glycoprotein Stable Signal Peptide Is Critical for Membrane Fusion but Dispensable for Virion Morphogenesis.
York J; Nunberg JH
J Virol; 2016 Sep; 90(18):8341-50. PubMed ID: 27412594
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
Shao J; Liu X; Ly H; Liang Y
J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230
[TBL] [Abstract][Full Text] [Related]
19. Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains.
Capul AA; Perez M; Burke E; Kunz S; Buchmeier MJ; de la Torre JC
J Virol; 2007 Sep; 81(17):9451-60. PubMed ID: 17581989
[TBL] [Abstract][Full Text] [Related]
20. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
Zhang X; Tang K; Guo Y
Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
